Log in to save to my catalogue

Chylomicronaemia—current diagnosis and future therapies

Chylomicronaemia—current diagnosis and future therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1697213070

Chylomicronaemia—current diagnosis and future therapies

About this item

Full title

Chylomicronaemia—current diagnosis and future therapies

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Endocrinology, 2015-06, Vol.11 (6), p.352-362

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Primary chylomicronaemia affects ∼1:600 adult individuals; of these ∼95% are affected by polygenic inherited susceptibility and ∼5% show monogenic autosomal recessive inheritance
The 'chylomicronaemia syndrome' refers to the presence of at least one clinical feature accompanying primary chylomicronaemia, such as eruptive xanthomas,...

Alternative Titles

Full title

Chylomicronaemia—current diagnosis and future therapies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1697213070

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1697213070

Other Identifiers

ISSN

1759-5029

E-ISSN

1759-5037

DOI

10.1038/nrendo.2015.26

How to access this item